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INTRODUCTION
Nipple discharge is a symptom that commonly occurs in 
4.8% to 7.4% of patients that are referred to breast clinics [1-3]. 
Although intraductal papilloma is the most common underly-
ing cause of pathologic nipple discharge [4], previous studies 
have reported the incidence of breast cancer at 2.8% to 21.3% 
in these women [5-11]. Thus, the development of a reliable di-
agnostic strategy for detecting malignancy are important goals. 
Initial evaluation with physical examination and mammogra-
phy in patients with bloody nipple discharge is useful for de-
tecting high-risk cases [12]. However, the ability of mammo-
grams to detect intraductal lesions is limited, and other diag-
nostic procedures such as galactography and  ultra sound (US), 
have also been proposed. Breast US is a valuable, noninvasive 
imaging method that can be used to evaluate the morphologic 
features of a breast mass and its relationship to adjacent ductal 
structures in patients with dense breast tissue [5]. Further-
more, US is a useful adjunct after mammography for the de-
tection of nonpalpable breast cancer, particularly in dense 
breasts. One study reported that 32% of nonpalpable breast 
cancers were negative on mammography and could be detect-
ed only by US [13]. However, to our knowledge only a few 
studies have assessed the role of US in detecting nonpalpable 
breast cancer specifically in mammographically negative pa-
tients presenting with pathologic nipple discharge. Therefore, 
accurate interpretation of findings is essential for lesions that 
are only detectable by US.
The US Breast Imaging Reporting and Data System (BI-
RADS) is widely used in conjunction with its final assessment 
to predict the probability that a targeted breast lesion is malig-
nant [14]. However, BI-RADS and its final assessment do not 
contain a detailed lexicon that describes the morphology of 
ductal involvement, which is common in patients with pathol-
ogic nipple discharge. Also, there are no clear guidelines on 
what sonographic variables differentiate malignancy from be-
nign etiology based on clinical and radiologic assessment. 
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Purpose: The purpose of this study was to retrospectively inves-
tigate the reliability of breast ultrasound (US) Breast Imaging Re-
porting and Data System (BI-RADS) final assessment in mam-
mographically negative patients with pathologic nipple dis-
charge, and to determine the clinical and ultrasonographic vari-
ables associated with malignancy in this group of patients. 
Methods: A total of 65 patients with 67 mammographically nega-
tive breast lesions that were pathologically confirmed through 
US-guided biopsy were included. Results: Of the 53 BI-RADS 
category 4 and 5 lesions, eight (15.1%) were malignant (six duc-
tal carcinomas in situ, one invasive ductal carcinoma, and one 
solid papillary carcinoma). There was no malignancy among the 
remaining 14 category 3 lesions. Malignant lesions more fre-
quently displayed a round or irregular shape (75.0%, 6/8; 
p=0.030) and nonparallel orientation (33.3%, 4/12; p=0.029) 
compared to the benign lesions. The increase in the BI-RADS 
category corresponded with a rise in the malignancy rate 
(p=0.004). Conclusion: The BI-RADS lexicon and final assess-
ment of breast US reliably detect and characterize malignancy in 
mammographically negative patients with pathologic nipple dis-
charge. 
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The purpose of this study was to retrospectively investigate 
the reliability of breast US BI-RADS final assessment and US-
guided biopsy in mammographically negative patients with nipple 
discharge, and to determine the clinical and ultrasonographic 
variables associated with malignancy.
METHODS
Patient selection 
This study was approved by the Institutional Review Board 
of our institution, Yonsei University Medical Center, Sever-
ance Hospital, South Korea (IRB number: 4-2015-0286). The 
requirement for informed consent was waived. 
Study population
Using a computerized search of the database, all breast US 
performed for patients presenting with symptoms of pathol-
ogic nipple discharge were located. Pathologic nipple dis-
charge was defined as any unilateral and spontaneous clear 
discharge, or discharge with blood. From December 2009 to 
December 2014, a total of 222 patients presenting only with 
pathologic nipple discharge underwent diagnostic US. 
Among these women, 11 had bilateral pathologic nipple dis-
charge.
Patients were excluded from the study if mammography re-
sults were considered positive when there was a detectable le-
sion and further evaluation or biopsy was recommended (BI-
RADS categories: 0, 4 or 5; n= 35 breasts in 35 patients). Pa-
tients who did not undergo mammography at the time of US 
were also excluded (n= 38 breasts in 31 patients). Among the 
remaining 160 mammographically negative breasts, 54 breasts 
which underwent microdochectomy without US-guided bi-
opsy, five breast lesions which were not pathologically con-
firmed, and 17 breast lesions whose US-guided biopsy was 
performed later than 3 months after the initial US (n = 17) 
were excluded. Additionally, 17 breasts that had no imaging 
follow-up for at least 2 years after US-guided biopsy were also 
excluded. Therefore, the final study population included 65 
patients with 67 mammographically negative breast lesions 
that were pathologically confirmed through US-guided biopsy 
and underwent subsequent surgery or follow-up for at least 2 
years (Figure 1).
Image evaluation and biopsy
Mammography was performed using one of two dedicated 
full-field digital mammography units (Senographe 2000D, GE 
Healthcare, Milwaukee, USA; or Lorad/A Hologic, Danbury, 
USA). Standard craniocaudal and mediolateral oblique views 
were routinely obtained, and additional mammographic 
views were obtained as needed. Breast parenchymal pattern 
was assessed and recorded according to BI-RADS as follows: 
entirely fatty breast (A), scattered fibroglandular tissue (B), 
heterogeneously dense (C), or extremely dense (D) [15]. All 
patients underwent US examination using high-resolution US 
222 Breast US preformed for the  evaluation of nipple dischanrge
Mammography taken separately from US 
(38 cases)
BI-RADS mammography C0 or C4 or 
more (35 cases)
Mammography taken at the same time of US 
(195 cases)
BI-RADS mammography C1, C2 or C3 
(160 cases)
Figure 1. Flow chart of the study investigating the reliability of breast ultrasound Breast Imaging Reporting and Data System (BI-RADS) final assess-
ment in mammographically negative patients with nipple discharge and radiologic predictors of malignancy. 
US=ultrasound.
Exclusion
54  Microdochectomy performed without 
US-guided biopsy
  5  Breast lesions not pathologically 
confirmed
17  US-guided biopsy performed 3 months 
after initial US
17  No follow-up after US-guided biopsy
Pathologic diagnosis confirmed 
through US-guided biopsy 
65 patients with 67 breast 
lesions
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units with 5- to 10-MHz or 5- to 12-MHz linear-array trans-
ducers (HDI5000, Philips Advanced Technology Laboratories, 
Bothell, USA; Logic 9, GE Medical Systems, Milwaukee, USA; 
or iU22, Philips Medical Systems, Bothell, USA). Bilateral 
whole-breast scanning was performed at every examination, 
with the patient in the supine position and the patient’s arm 
raised above the head. B-mode with spatial compound imag-
ing was used as the default; Doppler and harmonic imaging 
were used if necessary. Depending on breast tissue composi-
tion and thickness, the US frequency (MHz) and the amount 
of compound imaging were adjusted to enhance spatial reso-
lution or tissue penetration. Breast US examinations were 
performed by one of 15 board-certified radiologists with 1 to 
15 years of experience in breast imaging. The radiologist per-
forming the US determined the final assessment category ac-
cording to BI-RADS by assessing the lesion characteristics by 
BI-RADS lexicon (Figures 2, 3) [15].
For patients with nipple discharge in our hospital, image-
Figure 2. Radiologic findings of a 38-year-old woman with a several-week history of spontaneous serous discharge from the right nipple. (A) Medio-
lateral mammography of the both breast shows dense breasts with no abnormalities to explain right nipple discharge (Breast Imaging Reporting and 
Data System [BI-RADS] category 1). (B) Longitudinal ultrasound images show a 2.0 cm sized isoechoic, oval shaped, microlobulated mass with par-
allel orientation which was located at 1 o’clock 2 cm from nipple (BI-RADS category 3). Ultrasound-guided vacuum-assisted biopsy was performed 
and the pathologic result was consistent with fibrocystic disease with stromal fibrosis. After the procedure, the patient had no persistent nipple dis-
charge, and no malignancy was detected during a 2-year follow-up period.
A B
Figure 3. Radiologic findings of a 73-year-old woman with a 1-week history of spontaneous bloody discharge from the right nipple. (A) Mediolateral 
mammography of right breast shows no definite abnormality to explain right bloody nipple discharge. Transverse (B) and longitudinal (C) ultrasound 
images of the right breast show a 1.0 cm sized isoechoic, irregularly shaped, spiculated mass with nonparallel orientation (Breast Imaging Reporting 
and Data System category 5) which was located at 8 o’clock 1 cm from nipple. Ultrasound-guided biopsy was performed, and the pathologic result 
was consistent with ductal carcinoma in situ. Subsequent surgery was performed.
A B C
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guided biopsies were recommended for patients with BI-
RADS category 4 or 5 breast lesions identified by mammogra-
phy or US. Image-guided biopsies were also performed in pa-
tients with BI-RADS category 3 if desired by the patient or 
clinical physician.
US-guided percutaneous biopsy was performed using a 
14-gauge automated core needle (Stericut with coaxial; TSK 
Laboratory, Tochigi, Japan) or an 8- or 11-gauge vacuum-as-
sisted probe (Mammotome; Ethicon Endo-Surgery Inc., 
Cincinnati, USA), as previously described [16]. Subsequent 
surgical excisional biopsy was performed under US-guided 
localization. 
Retrospective image review
All US features of the breast lesions were retrospectively re-
viewed and re-evaluated according to the fifth BI-RADS lexi-
con (American College of Radiology 2013) [15] by consensus 
of two dedicated breast imaging radiologists with 1 and 15 
years of experience, respectively. The radiologists were blinded 
to the final pathologic diagnosis of all breast lesions. The final 
assessment category of breast US BI-RADS was not re-evalu-
ated and was determined prospectively at the time when US 
was performed. 
US features were classified according to BI-RADS lexicon 
as follows: tissue composition (homogeneous-fat, homoge-
neous-fibroglandular, or heterogeneous), shape (oval, round, 
or irregular), orientation (parallel or not parallel), margin (cir-
cumscribed, indistinct, angular, microlobulated, or spiculat-
ed), echo pattern (anechoic, hyperechoic, complex, hypoecho-
ic, isoechoic, or heterogeneous), posterior features (none, en-
hancing, or shadowing) and calcification (present or absent).
Furthermore, the ductal involvement pattern was reviewed 
and classified into three groups: a single mass not associated 
with a duct, a mass incompletely filling a duct, and a mass 
completely filling or extending outside the duct [17]. If a le-
sion was associated with ducts, the ductal wall irregularity was 
assessed further. There were also single masses that were not 
intraductal, but showed adjacent ductal dilatation that seemed 
to have no connection to the mass. Thus, the existence of ad-
jacent ductal dilatation was also recorded. The number of in-
volved branch ducts was noted as zero (0), one (1), two (2) or 
more. A retrospective review of US images was performed us-
ing digitized static images on a 5-MP monochrome display 
monitor (ME551 i2; Totoku Electric Co., Ltd., Tokyo, Japan) 
on a picture archiving and communication system.
Data collection and statistical analysis
Clinical and radiologic records were reviewed for patient 
age, the site of nipple discharge (right, left, or both breasts), le-
sion size, and distance from the nipple. The radiologists per-
forming the US recorded the direction of nipple discharge, le-
sion size (maximal diameter), and distance from the nipple.
Follow-up data, including recurrence of nipple discharge, 
were reviewed by examining medical records. Surgical reports 
were reviewed to ascertain or rule out malignancy, both at the 
biopsied lesion and in other aspects of the remaining breast. 
The reference standards for final diagnosis were based on 
pathologic results and follow-up records. Patients were con-
sidered to have breast cancer if histopathologic reports of per-
cutaneous biopsy or surgical specimens were positive for 
breast cancer. If biopsy results showed indeterminate pathol-
ogy such as atypical ductal hyperplasia, information from sur-
gical specimens was regarded as the final pathology. The final 
diagnosis was considered negative if there was no evidence of 
malignancy in follow-up imaging or medical record review 
within 2 years of the initial benign biopsy performed as a ra-
diologic intervention in response to pathologic nipple dis-
charge. The malignancy rate in mammographically occult and 
sonographically suspicious lesions in patients with pathologic 
nipple discharge was calculated.
For statistical analysis, Fisher exact tests were performed for 
comparison of nonparametric variables such as US features, 
and Mann-Whitney U-tests were performed for comparison 
of parametric variables, including age, lesion size, and distance 
from the nipple. Fisher exact test, Mann-Whitney U-test, and 
Cochran-Mantel-Haenszel tests were performed to establish 
the association between BI-RADS category and malignancy 
rate. 
Statistical analyses were performed with the SAS system for 
Windows version 9.2 (SAS Institute Inc., Cary, USA). A p-value<  
0.05 indicated statistical significance.
RESULTS
In all 67 cases, US-guided core needle biopsy or vacuum-
assisted excision was performed for pathologic diagnosis. 
Among 67 breast lesions, surgery was performed subsequent-
ly for 43 breast lesions in 43 patients, for the following reasons: 
(1) presence of malignancy (n= 5); (2) atypical pathologic re-
ports (n= 4); (3) complete excisional biopsies for papillary or 
phyllodes tumor (n= 22); and (4) symptom control (n= 12). 
According to surgical reports, no malignancy was identified 
in these cases, other than at the local site. The remaining 24 
patients did not undergo surgery but received clinical or im-
aging follow-up. The final diagnoses for the 67 breast lesions 
revealed eight malignancies (six ductal carcinoma in situ 
[DCIS], one invasive ductal carcinoma [IDC], and one solid 
papillary carcinoma), and 59 benign diseases (31 papillomas, 
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13 fibrocystic disease, four fibroadenomas, three ductectasias, 
two atypical ductal hyperplasias, two columnar cell changes, 
one benign phyllodes tumor, one complex sclerosing lesion, 
one stromal fibrosis, and one papillary apocrine hyperplasia). 
Among the eight malignant lesions, three were confirmed to 
be malignant on surgical excision, and exhibited atypical 
pathologic features based on the US-guided biopsy. All pathol-
ogically proven benign lesions were followed up for 2 years, 
and no malignancies developed during the follow-up period. 
Thus, the malignancy rate in mammographically occult and 
sonographically detected lesions (category 4 and 5) in patients 
with nipple discharge was 15.1% (8/53).
The ultrasonographic findings of benign and malignant 
breast lesions in patients with nipple discharge are shown in 
Table 1. The mean age was 47.5 years (standard deviation, 12.0 
years; range, 26–78 years). The lesion size and distance from 
the nipple were not significantly different between benign and 
malignant groups (p= 0.377 and p= 0.568, respectively). Ma-
lignant breast lesions more frequently showed round or irreg-
ular (75.0%, 6/8) shape compared to benign lesions (32.2%, 
19/59; p = 0.030). Among 42 oval-shaped lesions, 95.2% 
(40/42) proved to be benign. Malignant lesions more fre-
quently showed nonparallel orientation (33.3%, 4/12) com-
pared to benign lesions (7.3%, 4/55; p= 0.029). However, oth-
er radiologic findings (such as the presence of calcifications, 
tissue composition, margin, echogenicity, and posterior fea-
tures), were not significantly different between benign and 
malignant breast lesions.
The morphologic pattern of duct involvement (the degree 
of expansion or filling of the duct by the mass) was not signifi-
cantly different between benign and malignant breast lesions. 
However, all seven masses that incompletely filled the duct 
were benign. Of eight malignant lesions, six were single mass-
es showing no association with ducts, and two were intra-
ductal, with one completely filling the duct and one extending 
outside the duct. Ductal dilatation adjacent to the mass, or the 
number of involved branch ducts, were not significantly dif-
ferent between benign and malignant groups (p= 0.465 and 
p= 0.554, respectively). Among 27 lesions that were associated 
with ducts, six masses showed irregular ductal wall changes 
and only one case (16.7%, 1/6) was confirmed as DCIS.
Table 2 shows the BI-RADS category of breast US in both 
benign and malignant breast lesions. The malignancy rate for 
each BI-RADS category was as follows: category 3, 0% (0/14); 
category 4, 13.5% (7/52); and category 5, 100% (1/1). The 
trend of BI-RADS category was significantly different between 
the benign and malignant groups (p= 0.004). The increase in 
the BI-RADS category corresponded with a rise in the malig-
nancy rate (p= 0.004).
Table 1. Ultrasonographic findings in benign and malignant breast le-









Age (yr)* 46.8±11.3 52.5±16.6 0.456
Size (cm)* 1.1±4.2 1.4±8.7 0.377
Distance from the nipple (cm)† 1.0 (0.0–6.0) 1.0 (0.0–7.0) 0.568
Tissue composition 0.497
   Homogeneous fat  2 (66.7)  1 (33.3)
   Homogeneous fibroglandular 28 (90.3) 3 (9.7)
   Heterogeneous 29 (87.9)  4 (12.1)
Shape 0.030
   Oval 40 (95.2) 2 (4.8)
   Round  9 (75.0)  3 (25.0)
   Irregular 10 (76.8)  3 (23.1)
Orientation 0.029
   Parallel 51 (97.7) 4 (7.3)
   Not parallel  8 (66.7)  4 (33.3)
Margin 0.278
   Circumscribed 21 (95.5) 1 (4.5)
   Indistinct  6 (75.0)  2 (25.0)
   Angular   1 (100.0) 0 
   Microlobulated 29 (87.9)  4 (12.1)
   Spiculated  2 (66.7)  1 (33.3)
Echogenicity 0.609
   Hypoechoic 18 (90.0)  2 (10.0)
   Isoechoic 32 (84.2)  6 (15.8)
   Mixed (solid and cystic)   8 (100.0) 0 
   Heterogeneous   1 (100.0) 0 
Posterior features 0.444
   None 43 (87.8)  6 (12.2)
   Enhancement 14 (93.3) 1 (6.7)
   Shadowing  2 (66.7)  1 (33.3)
Calcification 1.000
   None 56 (87.5)  8 (12.5)
   Microcalcification in mass   3 (100.0) 0 
Association with ducts 0.751
   Single mass not associated 
with duct
34 (85.0)‡   6 (15.0)‡
   Mass incompletely filling the 
duct
 7 (100.0) 0 
   Mass completely filling the 
duct or extending outside 
the duct
18 (90.0) 2 (10.0)
Adjacent ductal dilatation 0.465
   No 27 (84.4)  5 (15.6)
   Yes 32 (91.4) 3 (8.6)
Branch duct 0.554
   0 45 (88.2)  6 (11.8)
   1 12 (92.3) 1 (7.7)
   2 or more  2 (66.7)  1 (33.3)
*Mean±SD; †Median (range); ‡Seven among 34 benign lesions (20.6%) and 
one among six malignant lesions (16.7%) showed adjacent ductal changes.
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DISCUSSION
Breast US has conventionally been used as a complement to 
mammography, as it is useful for lesion detection and charac-
terization in women with dense breasts, without the risk of a 
radiation hazard. Previous studies have reported that high-
resolution US is a valuable diagnostic method in patients with 
pathologic nipple discharge and is therefore a valuable alter-
native to galactography [5,18]. To our knowledge, there have 
been few studies regarding the value of US in mammographi-
cally negative patients with pathologic nipple discharge. In 
our study, the malignancy rate in mammographically-negative 
and those breast lesions only detected by US was 15.1% (8/53). 
This value is slightly higher than the previously reported ma-
lignancy rate ranging from 11.7% to 12.5% for mammograph-
ically-negative breasts with lesions that were only detected by 
US [5,19]. Our result, even in diagnostic settings with nipple 
discharge, is in line with previous studies that showed adding 
a screening US for women with increased risk of breast cancer 
resulted in an increased number of false-positive findings as 
well as in an increased cancer detection rate [20,21]. Mean-
while, by adding US and subsequent US-guided biopsy to 
negative mammogram, 15.1% of malignancy (8/53) was con-
firmed without another invasive procedure such as galacto-
graphy prior to surgery.
In our study, among various ultrasound features, round or 
irregular shape and not parallel orientation of breast lesions 
were associated with malignancy in patients with pathologic 
nipple discharge. This finding is consistent with previous 
studies that reported nodules with irregular shape or nonpar-
allel orientation are likely to be malignant in women with or 
without nipple discharge [15]. Meanwhile, Nakahara et al. [22] 
reported that hypoechoic masses with an irregular margin 
were more likely to be malignant. However, echogenicity 
showed no significant difference between the benign and ma-
lignant group, probably because only mammographically 
negative lesions were included in our study, as they showed 
mild radiographic changes. Though excluded in the BI-RADS 
lexicon, detailed ductal involvement patterns were investigat-
ed in our study, as they may be helpful in diagnosing malig-
nancy in patients with pathologic nipple discharge. However, 
we found that the ductal involvement pattern was not signifi-
cantly different between benign and malignant breast lesions, 
which might be due to the small number of intraductal breast 
lesions examined in our study. There were no malignancies in 
seven cases of intraductal masses that incompletely filled the 
duct, consistent with a previous study by Kim et al. [17], who 
reported no malignancies in a total of 37 intraductal masses 
incompletely filling the duct. Thus, we can consider US fol-
low-up for masses that incompletely fill the duct. In their 
study, malignant intraductal masses were more likely to in-
volve the branch duct than benign intraductal masses [17]. 
However, there was no significant association between malig-
nancy and branch duct involvement in our study, which may 
be due to the small number of breast lesions involving the 
branch ducts. Also, there may be a bias in our study due to the 
limited enrollment of mammographically negative breast le-
sions. Among eight malignant lesions, six were single masses 
without visible ductal changes at the ultrasound which does 
not clearly explain the symptom of pathologic nipple dis-
charge. This result suggests that even in the patients with nip-
ple discharge, masses might be seen without detectable associ-
ated ductal changes. The ductal changes might be not well de-
lineated at the time of US if the symptom of nipple discharge 
is intermittent rather continuous. However, we did not assess 
whether the nipple discharge is intermittent or not in each pa-
tient and its association with malignancy. Besides, considering 
the fact that all the lesions were not detected at the mammo-
graphy, these masses might accompany less positive findings 
also at the US. Our study at least suggests that in the patients 
with nipple discharge showing negative mammogram, the 
masses could be seen without expected ductal changes and 
there is also possibility of malignancy in these cases. 
Previous studies have shown that the sensitivity of breast 
US in patients with nipple discharge ranged from 36% to 80% 
[5,19,23,24]. In our study, all mammographically negative 
malignant lesions were detected by US, at a sensitivity of 
100%. There are several possible reasons for the high US sen-
sitivity in our study. First, all the US BI-RADS category 1 or 2 
lesions for which the US guided biopsy was not performed 
were excluded in our study. Also, breast lesions that were only 
confirmed through surgery without US-guided biopsy were 
also excluded; therefore, the sensitivity of breast US may have 
been lower if malignancy were detected in these excluded cas-
es. Thus, the high sensitivity of breast US could be largely ex-
Table 2. Relationship between ultrasound BI-RADS category and pa-








BI-RADS category 0.040 0.004
  3  14 (100.0) 0 
  4A 42 (87.5) 6 (12.5)
  4B  3 (75.0) 1 (25.0)
  5      0  1 (100.0)
BI-RADS=Breast Imaging Reporting and Data System.
*Fisher exact test, Mann-Whitney U-test; †Cochran-Mantel-Haenszel test.
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plained by our study design, which is one of the limitations of 
the study. However, among the benign lesions at biopsy, there 
was no malignancy other than the biopsied lesions, which 
suggests that US accurately detected the most suspicious le-
sions in each breast accurately. Furthermore, applying the BI-
RADS lexicon and final assessment during US interpretation 
[15] may have also led to the high sensitivity of US in our 
study. Previous studies of US in patients with nipple discharge 
were conducted before [24] or during [5,23] US BI-RADS 
publication. Additionally, only specialized breast radiologists 
who routinely perform at least 300 breast US exams per 
month in our institution were involved, which may explain 
the high sensitivity of breast US in our study.
In patients with pathologic nipple discharge, higher US BI-
RADS categories correlated with increased malignancy rates. 
Also, the malignancy yield rate for each category was compa-
rable to the likelihood of malignancy rate [25]. Although the 
current BI-RADS lexicon and final assessment have not been 
well established in the evaluation of intraductal lesions [17,26], 
our results suggest that BI-RADS reliably predicts malignancy 
as far as US detects positive findings in mammographically 
negative patients with nipple discharge. 
It has been reported that adding US to mammography dur-
ing preoperative evaluation in patients with pathologic nipple 
discharge may detect an additional 26.3% of breast cancers 
[27], and that US is more useful in patients who have more 
clinical features of nipple discharge [19]. Furthermore, our 
study demonstrated that US BI-RADS itself reliably classifies 
breast lesions that are only detected by US. According to Bahl 
et al. [19], most lesions considered positive on US were intra-
ductal masses or ectatic ducts with echogenic material or ret-
roareolar masses without a definite intraductal component. 
However, there was no description of how the final US BI-
RADS category was determined. In our study, we determined 
the final US category by assessing its detailed characteristics 
with BI-RADS lexicon, and all lesions were pathologically 
confirmed through US-guided biopsy, which gives strength to 
our results. Furthermore, we assessed whether the ductal wall 
shows irregularity among lesions that were associated with 
ducts. Though the number of masses showing irregular ductal 
wall changes was small, the positive predictive value of ductal 
wall irregularity was 16.7%, which is comparable to the malig-
nancy rate of category 4. Thus, we suggest that irregular ductal 
wall changes at the breast US should be considered as category 4.
There are some limitations to our study. First, this is a retro-
spective, single-institution study. Although the number of 
malignancy cases in our study cohort was too low to have sta-
tistical power, it suggests several suspicious findings of breast 
US especially in mammographically negative patients with 
nipple discharge. Second, breast lesions of US BI-RADS cate-
gory 1 or 2 were excluded; as such, we cannot assess the reli-
ability of US BI-RADS in these groups. Thus, further studies 
are required to fully assess the reliability of US BI-RADS in 
mammographically negative patients with nipple discharge. 
Third, we excluded the cases where the breast lesions were 
confirmed through surgery, rather than US-guided biopsy, to 
ascertain the exact correlation between BI-RADS final assess-
ment and findings in the pathology report. This selection bias 
might have led us to miss any potential malignancy in these 
excluded cases. In conclusion, the BI-RADS lexicon and final 
assessment of breast US reliably detects and characterizes ma-
lignancy in mammographically negative patients with pathol-
ogic nipple discharge. Among US BI-RADS lexicons, the 
round or irregular shape, and not the parallel orientation of 
breast lesions, were associated with malignancy in mammo-
graphically negative patients with pathologic nipple discharge.
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